• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 A1 作为胰腺癌的新型标志物:生物信息学分析和实验验证。

, and as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Experiments Validation.

机构信息

College of Public Health, Zhengzhou University, Zhengzhou, China.

Laboratory of Molecular Biology, Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital), Zhengzhou, China.

出版信息

Front Immunol. 2021 Mar 18;12:649551. doi: 10.3389/fimmu.2021.649551. eCollection 2021.

DOI:10.3389/fimmu.2021.649551
PMID:33815409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8015801/
Abstract

Pancreatic cancer is a lethal malignancy with a poor prognosis. This study aims to identify pancreatic cancer-related genes and develop a robust diagnostic model to detect this disease. Weighted gene co-expression network analysis (WGCNA) was used to determine potential hub genes for pancreatic cancer. Their mRNA and protein expression levels were validated through reverse transcription PCR (RT-PCR) and immunohistochemical (IHC). Diagnostic models were developed by eight machine learning algorithms and ten-fold cross-validation. Four hub genes (, and ) were identified based on bioinformatics. RT-PCR showed that the four hub genes were expressed at medium to high levels, IHC revealed that their protein expression levels were higher in pancreatic cancer tissues. For the panel of these four genes, eight models performed with 0.87-0.92 area under the curve value (AUC), 0.91-0.94 sensitivity, and 0.84-0.86 specificity in the validation cohort. In the external validation set, these models also showed good performance (0.86-0.98 AUC, 0.84-1.00 sensitivity, and 0.86-1.00 specificity). In conclusion, this study has identified four hub genes that might be closely related to pancreatic cancer: , and . Four-gene panels might provide a theoretical basis for the diagnosis of pancreatic cancer.

摘要

胰腺癌是一种预后不良的致命恶性肿瘤。本研究旨在鉴定胰腺癌相关基因,并开发一种稳健的诊断模型来检测这种疾病。加权基因共表达网络分析(WGCNA)用于确定胰腺癌的潜在关键基因。通过逆转录 PCR(RT-PCR)和免疫组织化学(IHC)验证其 mRNA 和蛋白质表达水平。通过八种机器学习算法和十折交叉验证开发了诊断模型。基于生物信息学确定了四个枢纽基因(、和)。RT-PCR 显示这四个枢纽基因的表达水平处于中高水平,免疫组织化学显示其蛋白表达水平在胰腺癌组织中更高。对于这四个基因的组合,八个模型在验证队列中具有 0.87-0.92 的曲线下面积值(AUC)、0.91-0.94 的灵敏度和 0.84-0.86 的特异性。在外部验证集中,这些模型也表现出良好的性能(0.86-0.98 AUC、0.84-1.00 灵敏度和 0.86-1.00 特异性)。总之,本研究鉴定了四个可能与胰腺癌密切相关的枢纽基因:、和。四基因组合可能为胰腺癌的诊断提供理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/07f4c7f25351/fimmu-12-649551-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/b546781dc8a9/fimmu-12-649551-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/3382b08358fe/fimmu-12-649551-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/fa3db0cb4fd1/fimmu-12-649551-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/07f4c7f25351/fimmu-12-649551-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/b546781dc8a9/fimmu-12-649551-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/3382b08358fe/fimmu-12-649551-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/fa3db0cb4fd1/fimmu-12-649551-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d9f/8015801/07f4c7f25351/fimmu-12-649551-g0007.jpg

相似文献

1
, and as Novel Panel for Pancreatic Cancer: A Bioinformatics Analysis and Experiments Validation.载脂蛋白 A1 作为胰腺癌的新型标志物:生物信息学分析和实验验证。
Front Immunol. 2021 Mar 18;12:649551. doi: 10.3389/fimmu.2021.649551. eCollection 2021.
2
Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.基于生物信息学分析和有监督学习方法鉴定胰腺癌诊断价值的关键基因。
World J Surg Oncol. 2018 Nov 14;16(1):223. doi: 10.1186/s12957-018-1519-y.
3
An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.集成微阵列分析揭示胰腺癌有显著的诊断和预后生物标志物。
Med Sci Monit. 2020 Apr 1;26:e921769. doi: 10.12659/MSM.921769.
4
Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.转录组数据的荟萃分析确定了一种新型的5基因胰腺癌分类器。
Oncotarget. 2016 Apr 26;7(17):23263-81. doi: 10.18632/oncotarget.8139.
5
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.胰腺癌患者生存预后不良的独立预测因素的筛选与验证
Pathol Oncol Res. 2021 Jul 12;27:1609868. doi: 10.3389/pore.2021.1609868. eCollection 2021.
6
Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.基于综合基因表达谱分析鉴定与胰腺导管腺癌相关的枢纽基因和调控因子
Discov Med. 2019 Sep;28(153):159-172.
7
Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer.生物信息学分析揭示 TSPAN1 是胰腺癌进展和预后的候选生物标志物。
Bosn J Basic Med Sci. 2021 Feb 1;21(1):47-60. doi: 10.17305/bjbms.2020.5096.
8
Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.筛选和验证胰腺导管腺癌患者的核心生物标志物。
Math Biosci Eng. 2019 Nov 6;17(1):910-927. doi: 10.3934/mbe.2020048.
9
Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.鉴定与胰腺癌相关的 5 个 miRNA 特征和 hub miRNA-mRNA 相互作用。
Oncol Rep. 2019 Jan;41(1):292-300. doi: 10.3892/or.2018.6820. Epub 2018 Oct 24.
10
Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.基于基因芯片数据集鉴定胰腺导管腺癌与正常胰腺组织中的差异表达基因。
Mol Med Rep. 2019 Aug;20(2):1901-1914. doi: 10.3892/mmr.2019.10414. Epub 2019 Jun 24.

引用本文的文献

1
Organoid in droplet: Production of uniform pancreatic cancer organoids from single cells.液滴中的类器官:从单细胞生成均匀的胰腺癌类器官
Mater Today Bio. 2025 Apr 12;32:101765. doi: 10.1016/j.mtbio.2025.101765. eCollection 2025 Jun.
2
Bioinformatics-based screening of key genes associated with gemcitabine resistance in advanced pancreatic ductal adenocarcinoma.基于生物信息学的晚期胰腺导管腺癌吉西他滨耐药相关关键基因筛选
Transl Cancer Res. 2024 Dec 31;13(12):6947-6955. doi: 10.21037/tcr-2024-2374. Epub 2024 Dec 27.
3
Tetraspanins in digestive‑system cancers: Expression, function and therapeutic potential (Review).

本文引用的文献

1
A Review of Pancreatic Cancer: Epidemiology, Genetics, Screening, and Management.胰腺癌综述:流行病学、遗传学、筛查与管理
Open Access Maced J Med Sci. 2019 Feb 14;7(4):663-671. doi: 10.3889/oamjms.2019.104. eCollection 2019 Feb 28.
2
Breast Cancer Prognosis Using a Machine Learning Approach.基于机器学习方法的乳腺癌预后分析
Cancers (Basel). 2019 Mar 7;11(3):328. doi: 10.3390/cancers11030328.
3
Molecular mechanism of triple-negative breast cancer-associated BRCA1 and the identification of signaling pathways.三阴性乳腺癌相关BRCA1的分子机制及信号通路的鉴定
消化系统癌症中的四跨膜蛋白:表达、功能与治疗潜能(综述)。
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13324. Epub 2024 Sep 6.
4
A Comparison of Tools That Identify Tumor Cells by Inferring Copy Number Variations from Single-Cell Experiments in Pancreatic Ductal Adenocarcinoma.通过推断胰腺导管腺癌单细胞实验中的拷贝数变异来识别肿瘤细胞的工具比较
Biomedicines. 2024 Aug 5;12(8):1759. doi: 10.3390/biomedicines12081759.
5
ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.ESCCPred:一种基于自身抗体谱的早期食管鳞状细胞癌诊断预测的机器学习模型。
Br J Cancer. 2024 Sep;131(5):883-894. doi: 10.1038/s41416-024-02781-w. Epub 2024 Jul 2.
6
Comparative Evaluation of Machine Learning Models for Subtyping Triple-Negative Breast Cancer: A Deep Learning-Based Multi-Omics Data Integration Approach.三阴性乳腺癌亚型机器学习模型的比较评估:基于深度学习的多组学数据整合方法
J Cancer. 2024 May 30;15(12):3943-3957. doi: 10.7150/jca.93215. eCollection 2024.
7
Tspan protein family: focusing on the occurrence, progression, and treatment of cancer.四跨膜蛋白家族:聚焦于癌症的发生、发展及治疗
Cell Death Discov. 2024 Apr 22;10(1):187. doi: 10.1038/s41420-024-01961-0.
8
Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy.跨膜丝氨酸蛋白酶 4 对接受手术联合辅助化疗的胰腺导管腺癌患者生存的影响。
Surg Today. 2024 Oct;54(10):1208-1219. doi: 10.1007/s00595-024-02824-y. Epub 2024 Apr 19.
9
Identification of hub genes to determine drug-disease correlation in breast carcinomas.鉴定枢纽基因以确定乳腺癌中的药物-疾病相关性。
Med Oncol. 2023 Dec 28;41(1):36. doi: 10.1007/s12032-023-02246-9.
10
EFHD1 expression is correlated with tumor-infiltrating neutrophils and predicts prognosis in gastric cancer.EFHD1表达与肿瘤浸润性中性粒细胞相关,并可预测胃癌预后。
Heliyon. 2023 Oct 14;9(10):e21062. doi: 10.1016/j.heliyon.2023.e21062. eCollection 2023 Oct.
Oncol Lett. 2019 Mar;17(3):2905-2914. doi: 10.3892/ol.2019.9884. Epub 2019 Jan 3.
4
TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.TSPAN1 通过 PLCγ 上调 MMP2 促进胰腺癌细胞迁移和侵袭。
Oncol Rep. 2019 Apr;41(4):2117-2125. doi: 10.3892/or.2019.6989. Epub 2019 Jan 30.
5
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.鉴定胰腺癌的候选诊断和预后生物标志物。
EBioMedicine. 2019 Feb;40:382-393. doi: 10.1016/j.ebiom.2019.01.003. Epub 2019 Jan 11.
6
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
7
Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data.通过转录组数据网络分析鉴定的膀胱癌新生物标志物
Front Oncol. 2018 Oct 12;8:450. doi: 10.3389/fonc.2018.00450. eCollection 2018.
8
Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis.通过基因共表达网络分析鉴定的乳腺癌预后基因
Front Oncol. 2018 Sep 11;8:374. doi: 10.3389/fonc.2018.00374. eCollection 2018.
9
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.基于血清生物标志物特征的液体活检用于早期胰腺癌的诊断。
J Clin Oncol. 2018 Oct 1;36(28):2887-2894. doi: 10.1200/JCO.2017.77.6658. Epub 2018 Aug 14.
10
Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model.基于共表达相似性构建肺腺癌早期诊断标志物并构建诊断模型
J Transl Med. 2018 Jul 20;16(1):205. doi: 10.1186/s12967-018-1577-5.